Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, ...

This ETF isn't as heralded as its larger relatives, but it's one to watch this month, and it could be a star next year.

The Invesco QQQ ETF has delivered a compound annual return of 10.5% since its inception in 1999, even after accounting for every sell-off, correction, and bear market -- including those triggered by ...

Some of my favorite stocks have become much cheaper recently, but ETFs remain a big focus of my investment strategy.

The Global X Artificial Intelligence & Technology ETF has been a big winner since its inception in 2018. The iShares A.I. Innovation and Tech Active ETF is relatively new, but it provides exposure to ...

Exchange-traded funds (ETFs) can be incredibly powerful investments for building long-term wealth. With enough time and consistency, it's possible to generate hundreds of thousands of dollars or more, ...

This fund is the seasoned veteran in the quantum computing ETF space. It does an admirable job of spreading bets across pure-play quantum stocks and broader technology companies. Unlike so many ...

Despite the availability of thousands of different exchange-traded funds (ETFs), many investors focus on a relatively small number of popular options. While there is nothing wrong with a broad-based S ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...